Industries > Pharma > Biopharmaceutical Third Party Logistics (3PL) Market Report 2019-2029
Biopharmaceutical Third Party Logistics (3PL) Market Report 2019-2029
Forecasts by Supply Chain (Cold Chain, Non-Cold Chain), by Service Service Type (Transportation (Air Freight, Sea Freight, Overland Transportation), Warehousing and Storage, Others) Plus Analysis of Leading Companies
The comprehensive report offers market estimation and forecast for the period ranging 2019 – 2029 for leading national markets and the rest of the world. Moreover, the report contains dedicated leading companies covering leading companies in the field of Biopharmaceutical Third Party Logistics (3PL).
The Biopharmaceutical Third Party Logistics (3PL) Market 2019-2029 report will be of value to anyone who wants to better understand the biopharmaceutical 3PL market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Biopharmaceutical Third Party Logistics (3PL) industry.
Biopharmaceutical Third Party Logistics (3PL) Market 2019-2029, By Service Type
– Transportation
– Air Freight
– Sea Freight
– Overland Transportation
– Warehousing and Storage
– Others
Biopharmaceutical Third Party Logistics (3PL) Market 2019-2029, By Supply Chain
– Cold Chain
– Non-cold Chain
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Global Biopharmaceutical Third Party Logistics (3PL) Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report Includes:
1.5. Who is This Report For?
1.6. Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. Associated Visiongain Reports
1.9. About Visiongain
2. Introduction to the Biopharmaceutical Third Party Logistics (3PL) Market
2.1. What is Biopharmaceutical Third Party Logistics (3PL)?
2.2. Service Types of Supply Chain for Biopharmaceutical Third Party Logistics (3PL)
2.2.1. Cold Chain
2.2.2. Non-Cold Chain
2.3. Service Types of Service of Biopharmaceutical Third Party Logistics (3PL)
2.3.1. Transportation
1. Air Freight
2. Sea Freight
3. Overland Transportation
2.3.2. Warehousing and Storage
2.3.3. Others
2.4. Factors Impacting Biopharmaceutical Third Party Logistics (3PL) Market
3. Biopharmaceutical Third Party Logistics (3PL) Market Outlook
3.1. Trends in Biopharmaceutical Third Party Logistics (3PL) Industry
3.2. Market Drivers and Restraints
3.3. Biopharmaceutical Third Party Logistics (3PL) future opportunities
3.4. PESTEL Analysis
3.5. Penetration & Growth Prospect Mapping
3.6. Industry Analysis - Porter’s
4. Biopharmaceutical Third Party Logistics (3PL) Market By Supply Chain 2019 – 2029
4.1. Biopharmaceutical Third Party Logistics (3PL) Market Outlook By Supply Chain 2019 – 2029
4.2. Cold Chain Revenue Forecast 2019 – 2029
4.3. Non-Cold Chain Revenue Forecast 2019 – 2029
5. Biopharmaceutical Third Party Logistics (3PL) Market By Service Service Type 2019 – 2029
5.1. Biopharmaceutical Third Party Logistics (3PL) Market Outlook By Service Service Type 2019 – 2029
5.2. Transportation Revenue Forecast 2019 – 2029
5.3. Warehousing and Storage Revenue Forecast 2019 – 2029
5.4. Others Revenue Forecast 2019 – 2029
6. Biopharmaceutical Third Party Logistics (3PL) Market By Region 2019 – 2029
6.1. Biopharmaceutical Third Party Logistics (3PL) Market Outlook By Region 2019 – 2029
6.2. North America Revenue Forecast 2019 – 2029
6.2.1. U.S. Revenue Forecast 2019 – 2029
6.2.2. Canada Revenue Forecast 2019 – 2029
6.3. Europe Revenue Forecast 2019 – 2029
6.3.1. Germany Revenue Forecast 2019 – 2029
6.3.2. UK Revenue Forecast 2019 – 2029
6.3.3. Russia Revenue Forecast 2019 – 2029
6.4. Asia Pacific Revenue Forecast 2019 – 2029
6.4.1. China Revenue Forecast 2019 – 2029
6.4.2. Japan Revenue Forecast 2019 – 2029
6.4.3. India Revenue Forecast 2019 – 2029
6.5. Rest of the World Revenue Forecast 2019 – 2029
6.5.1. Brazil Revenue Forecast 2019 – 2029
6.5.2. Saudi Arabia Revenue Forecast 2019 – 2029
7. The Leading Biopharmaceutical Third Party Logistics (3PL) Companies 2019 – 2029
7.1. Major Biopharmaceutical Third Party Logistics (3PL) Companies
7.2. AmerisourceBergen Corporation
7.3. KUEHNE + NAGEL
7.4. Kerry Logistics Network Limited
7.5. DB Schenker
7.6. DHL International GmbH
7.7. United Parcel Service of America, Inc.
7.8. SF Express
7.9. Agility
7.10. FedEx
7.11. List of other companies
8. SWOT Analysis of The Biopharmaceutical Third Party Logistics (3PL) Market
9. Conclusions & Recommendations
9.1. Key Findings in the Biopharmaceutical Third Party Logistics (3PL) Market
9.2. Recommendations for the Biopharmaceutical Third Party Logistics (3PL) Market
10. Glossary
List of Tables
10.1. Global Biopharmaceutical Third Party Logistics Market, 2019 & 2029 (USD billion)
10.2. Global Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.3. Global Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.4. North America Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.5. North America Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.6. North America Biopharmaceutical Third Party Logistics Market, by Country, 2019-2029 (USD billion)
10.7. U.S. Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.8. U.S. Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.9. Canada Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.10. Canada Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.11. Europe Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.12. Europe Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.13. Europe Biopharmaceutical Third Party Logistics Market, by Country, 2019-2029 (USD billion)
10.14. Germany Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.15. Germany Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.16. UK Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.17. UK Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.18. Russia Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.19. Russia Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.20. Asia Pacific Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.21. Asia Pacific Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.22. Asia Pacific Biopharmaceutical Third Party Logistics Market, by Country, 2019-2029 (USD billion)
10.23. Japan Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.24. Japan Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.25. China Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.26. China Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.27. India Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.28. India Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.29. Rest of the World Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.30. Rest of the World Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.31. Rest of the World Biopharmaceutical Third Party Logistics Market, by Country, 2019-2029 (USD billion)
10.32. Brazil Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.33. Brazil Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
10.34. Saudi Arabia Biopharmaceutical Third Party Logistics Market, by Service Type, 2019-2029 (USD billion)
10.35. Saudi Arabia Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2019-2029 (USD billion)
List of Figures
10.36. Research Methodology
10.37. Market Size Estimation Methodology
10.38. Forecasting Methodology
10.39. Global Biopharmaceutical Third Party Logistics Market, DRO Analysis
10.40. Global Biopharmaceutical Third Party Logistics Market, Company Share Analysis
10.41. Global Biopharmaceutical Third Party Logistics Market, Interview Demographics
10.42. PESTEL Analysis
10.43. Global Biopharmaceutical Third Party Logistics Market Segmentation
10.44. Global Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Service Type, 2019 & 2029
10.45. Global Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Supply Chain, 2019-2029
10.46. Global Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Geography, 2019-2029
10.47. North America Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Service Type, 2019 & 2029
10.48. North America Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Supply Chain, 2019-2029
10.49. North America Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Country, 2019-2029
10.50. Europe Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Service Type, 2019 & 2029
10.51. Europe Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Supply Chain, 2019-2029
10.52. Europe Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Country, 2019-2029
10.53. Asia Pacific Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Service Type, 2019 & 2029
10.54. Asia Pacific Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Supply Chain, 2019-2029
10.55. Asia Pacific Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Country, 2019-2029
10.56. Rest of the World Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Service Type, 2019 & 2029
10.57. Rest of the World Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Supply Chain, 2019-2029
10.58. Rest of the World Biopharmaceutical Third Party Logistics Market Share and Y-o-Y Growth, by Country, 2019-2029
AmerisourceBergen Corporation
KUEHNE + NAGEL
Kerry Logistics Network Limited
DB Schenker
DHL International GmbH
United Parcel Service of America, Inc.
SF Express
Agility
FedEx
Download sample pages
Complete the form below to download your free sample pages for Biopharmaceutical Third Party Logistics (3PL) Market Report 2019-2029Download sample pages
Complete the form below to download your free sample pages for Biopharmaceutical Third Party Logistics (3PL) Market Report 2019-2029Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Latest Pharma news
Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031
Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.
08 January 2021
Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030
The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.
07 January 2021
Visiongain Publishes Inactivated Vaccines Market Report 2020-2030
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.
07 January 2021
Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031
The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.
06 January 2021